are they still compounding semaglutide Compounded (GLP-1) Compounded Semaglutide & Tirzepatide 2025:

As a general guideline, Semaglutide GLP-1 injections are typically prescribed to individuals with a BMI of 30 or above or 27 and above with at least one weight-related condition, such as high cholesterol, osteoarthritis, or sleep apnea

What you do not expect is burping up something that smells like rotten eggs at the worst possible moment

56 BrandKMGSaarelainenLSonajalgJBoutmyEFochCVrsmkiMet al

[DOI] [PMC free article] [PubMed] [Google Scholar] 89.Gutierrez AD, Gao Z, Hamidi V, Zhu L, Saint Andre KB, Riggs K, et al

in recent years, given benefits promoting weight loss

85% of participants Achieved an A1c of less than 7% Lost up to 10.6 kg (23.3 lbs) Improvements seen in 52 weeks Trial #5 Compared tirzepatide with placebo added to titrated insulin Glargine with or without metformin